GRI - GRI Bio, Inc.
2.4
0.120 5.000%
Share volume: 36,392
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$2.28
0.00
0.00%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 03-14-2025 | 05-15-2025 | 11-14-2025 | 01-30-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | ||||
| Operating expenses | 1.953 M | 3.051 M | 3.365 M | 2.664 M | |
| Selling general and admin | 1.125 M | 1.411 M | 1.596 M | 1.133 M | |
| Research and development | 828.000 K | 1.640 M | 1.769 M | 1.531 M | |
| Total expenses | 1.953 M | 3.051 M | 3.365 M | 2.664 M | |
| 56.22% | 10.29% | -20.83% | |||
| Operating income | -1.953 M | -3.051 M | -3.365 M | -2.664 M | |
| Ebit | -1.953 M | -3.051 M | -3.365 M | -2.664 M | |
| Pretax income | -1.947 M | -3.046 M | -3.359 M | -2.659 M | |
| 56.45% | 10.28% | -20.84% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -1.947 M | -3.046 M | -3.359 M | -2.659 M | |
| -56.45% | -10.28% | 20.84% |